Tim Haines

Chairman and Managing Partner at Abingworth
Summary
Tim Haines is a highly accomplished professional known for his extensive experience in the biotech and pharmaceutical industry.
Throughout his career, Tim has held various board positions in prominent companies such as Astex Therapeutics, Fovea, and Pixium Vision, among others.
He has a solid educational background, having earned a Master of Business Administration (MBA) from INSEAD, studied Strategic Marketing at Harvard Business School, and completed his BSc Hons at Exeter University.
Currently, Tim serves as the Chairman and Managing Partner at Abingworth, a position that underscores his leadership skills and strategic vision in the industry.
Prior to his role at Abingworth, he held key positions like CEO of Astex Pharmaceuticals, CEO at Intervascular Inc., and Patient Monitoring at Datascope, and General Manager at Baxter International Inc., showcasing his diverse expertise.
Apart from his corporate roles, Tim has been actively involved in the Investment Advisory Board of Oxford University Innovation and Novo BioInnovation Institute, demonstrating his commitment to nurturing innovations in the sector.
He has also been a part of significant associations such as the Biotech Industry Association and the Venture Committee of the British Venture Capital Association, contributing his knowledge and insights to the industry.
Tim's impressive journey includes successful acquisitions and collaborations, notably with companies like Otsuka, Sanofi Aventis, Pfizer, and Stryker, reflecting his strategic acumen and business acuity.
With his profound experience, Tim Haines continues to make significant contributions to the biotech and pharmaceutical landscape, driving innovation and fostering growth in the industry.